Cognition Therapeutics CEO Kenneth I. Moch Presenting at BioCentury Future Leaders Conference

Posted by & filed under News.

PITTSBURGH, April 3, 2017 — Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other neurocognitive disorders, announced that the company has been selected to present at the annual Future Leaders in the Biotech Industry conference hosted by BioCentury. Kenneth I. Moch,… Read more »